This article presents the results of a survey conducted to gain insight on the impact of the COVID-19 pandemic on biomanufacturing operations.
Stacy L. Springs
Advertisement
Stacy L. Springs, [email protected], is senior director of programs and executive director of Biomanufacturing Initiatives, MIT Center for Biomedical Innovation.
Articles by Stacy L. Springs
Advertisement
Latest Updated Articles
The Impact of SARS-CoV-2 on Biomanufacturing OperationsAugust 4th 2020
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Zumilokibart: Inside AbbVie's $10.9B Pipeline Bet
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
IPEC’s Excipient Information Package: A Standardized Communication Platform for Sharing Excipient Information as an Alternative to Questionnaires
5